TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes

One of the hallmarks of cancer is its unlimited replicative potential that needs a compensatory mechanism for the consequential telomere erosion. Telomerase promoter (TERTp) mutations were recently reported as a novel mechanism for telomerase re-activation/expression in order to maintain telomere length. Pancreatic endocrine tumors (PETs) were so far recognized to rely mainly on the alternative lengthening of telomeres (ALT) mechanism. It was our objective to study if TERTp mutations were present in pancreatic endocrine tumors (PET) and could represent an alternative mechanism to ALT. TERTp mutations were detected in 7% of the cases studied and were mainly associated to patients harbouring hereditary syndromes. In vitro, using PET-derived cell lines and by luciferase reporter assay, these mutations confer a 2 to 4-fold increase in telomerase transcription activity. These novel alterations are able to recruit ETS transcription factor members, in particular GABP-α and ETV1, to the newly generated binding sites. We report for the first time TERTp mutations in PETs and PET-derived cell lines. Additionally, our data indicate that these mutations serve as an alternative mechanism and in an exclusive manner to ALT, in particular in patients with hereditary syndromes.

The United States Environmental Protection Agency announces the availability of 1996 grants for research on endocrine disruptors, role of interindividual variation in human susceptibility to cancer, risk-based decisions for contaminated sediments.

Mode of access: Internet.

Understanding multiple endocrine neoplasia type 1.

Mode of access: Internet.

The effect of the disruption on the Hebrew thought of God.

Reprinted from the American journal of Semitic languages and literatures, vol. XXXII, no. 4, July, 1916.

Endocrine glands and the sympathetic system /

Mode of access: Internet.

The endocrine organs; an introduction to the study of internal secretion.

"Founded upon a course of lectures (Lane Medical Lectures) delivered at Stanford University, California, in the summer of 1913."

Endocrine therapy in general practice,

"Published in response to requests for the printing of a series f lectures given before a variety of medical organizations during the last two years."--Pref.

Endocrine therapy in general practice,

"References for further reading" at end of some of the chapters."

Endocrine therapy in general practice /

Includes bibliographical references and index.

Endocrine therapy in general practice,

"References for further reading" at end of some of the chapters."

History of the Church of Scotland, from the introduction of Christianity to the period of the disruption, May 18, 1843; with an introductory essay on the principles and constitution of the Church of Scotland.

Mode of access: Internet.

Current cancer research on endocrine neoplasms : epidemiology, etiology and related biology.

Prepared for the ICRDB Program by the Current Cancer Research Project Analysis Center.

Task force report issued pursuant to Senate Resolution 0051 95th General Assembly : a study of electro-muscular disruption technology (EMDT) employed by Illinois law enforcement and correctional officers : standards, policy and training : task force deliberations and recommendations.

"Issued June 30, 2007"